Form D · Pharmaceuticals
Pulmatrix Operating Company, Inc.
Lexington, MA · CIK 0001295524
Offering snapshot reported Jun 30, 2015 · SEC filing
- Reported sold
- $1.62M Offering amount: $1.62M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 13, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 30, 2015 | Initial | $1,621,422 | No comparison | 1 | SEC filing |
| Jun 30, 2015 | Initial | $10,000,000 | No comparison | 11 | SEC filing |
| Feb 22, 2013 | Amendment | $20,500,000 | $3,500,000vs Oct 26, 2012 | 11 | SEC filing |
| Oct 26, 2012 | Amendment | $17,000,000 | $12,000,000vs Aug 17, 2011 | 11 | SEC filing |
| Aug 17, 2011 | Initial | $5,000,000 | No comparison | 11 | SEC filing |
| Nov 2, 2009 | Initial | $15,452,728 | No comparison | 10 | SEC filing |
| Feb 17, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 9, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jun 14, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 10, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-242825
The total offering amount is based on the issuance of 589,608 shares of common stock in the merger with Pulmatrix, Inc. in respect of the shares offered by Pulmatrix Operating Company, Inc. at an assumed price of $2.75 per share received in the merger.
Source: Form D, filed Jun 30, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Clarke | Director, Executive |
| Robert Connelly | Director |
| David Edwards | Director |
| Mark Gabrielson | Director |
| Steven Gillis | Director |
| Kurt Graves | Director |
| David Hava | Executive |
| Michael Higgins | Director |
| David Maki | Director |
| Terry Mc Guire | Director |
| Terrance Mc Guire | Director |
| Scott Rocklage | Director |
| Lauren Silverman | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
99 Hayden Avenue Suite 390
Lexington, MA, 02421
Lexington, MA, 02421